L. Arreaza

646 total citations
19 papers, 468 citations indexed

About

L. Arreaza is a scholar working on Microbiology, Epidemiology and Molecular Medicine. According to data from OpenAlex, L. Arreaza has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Microbiology, 16 papers in Epidemiology and 3 papers in Molecular Medicine. Recurrent topics in L. Arreaza's work include Bacterial Infections and Vaccines (17 papers), Pneumonia and Respiratory Infections (16 papers) and Microbial infections and disease research (3 papers). L. Arreaza is often cited by papers focused on Bacterial Infections and Vaccines (17 papers), Pneumonia and Respiratory Infections (16 papers) and Microbial infections and disease research (3 papers). L. Arreaza collaborates with scholars based in Spain, France and Greece. L. Arreaza's co-authors include Julio A. Vázquez, L. de la Fuente, B. Alcalá, Celia Salcedo, S. Berrón, Raquel Abad, Xurxo Hervada, Juan Gestal, Colin Block and Paula Kriz and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L. Arreaza

19 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Arreaza Spain 12 295 250 137 128 52 19 468
Celia Salcedo Spain 9 199 0.7× 145 0.6× 66 0.5× 67 0.5× 17 0.3× 13 322
Geraldine L. Wiggins United States 10 114 0.4× 156 0.6× 64 0.5× 56 0.4× 40 0.8× 20 321
E. Laurent France 7 80 0.3× 71 0.3× 324 2.4× 308 2.4× 51 1.0× 16 484
Joseph J. Wanford United Kingdom 11 93 0.3× 110 0.4× 12 0.1× 64 0.5× 90 1.7× 19 329
Jessica A. Schuyler United States 9 155 0.5× 148 0.6× 10 0.1× 24 0.2× 106 2.0× 13 415
Lynn Steele‐Moore United States 10 45 0.2× 278 1.1× 22 0.2× 54 0.4× 77 1.5× 13 473
Rose Cheung Canada 11 46 0.2× 111 0.4× 15 0.1× 41 0.3× 55 1.1× 22 334
Inger Lill Anthonisen Norway 8 119 0.4× 140 0.6× 12 0.1× 17 0.1× 133 2.6× 12 347
Shakeel Mowlaboccus Australia 11 110 0.4× 123 0.5× 9 0.1× 21 0.2× 61 1.2× 35 309
Greg Tyrrell Canada 10 237 0.8× 76 0.3× 21 0.2× 34 0.3× 81 1.6× 11 488

Countries citing papers authored by L. Arreaza

Since Specialization
Citations

This map shows the geographic impact of L. Arreaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Arreaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Arreaza more than expected).

Fields of papers citing papers by L. Arreaza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Arreaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Arreaza. The network helps show where L. Arreaza may publish in the future.

Co-authorship network of co-authors of L. Arreaza

This figure shows the co-authorship network connecting the top 25 collaborators of L. Arreaza. A scholar is included among the top collaborators of L. Arreaza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Arreaza. L. Arreaza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vázquez, Julio A., et al.. (2006). Antibiotic resistant meningococci in Europe: Any need to act?. FEMS Microbiology Reviews. 31(1). 64–70. 24 indexed citations
2.
Salcedo, Celia, et al.. (2004). Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain. Journal of Medical Microbiology. 53(6). 515–518. 20 indexed citations
3.
Arreaza, L., et al.. (2003). Molecular Characterization of Ciprofloxacin Resistance of Gonococcal Strains in Spain. Sexually Transmitted Diseases. 30(5). 395–398. 17 indexed citations
4.
Arreaza, L., et al.. (2003). Dynamics of thepenAGene in Serogroup C Meningococcal Strains. The Journal of Infectious Diseases. 187(6). 1010–1014. 8 indexed citations
5.
Arreaza, L. & Julio A. Vázquez. (2003). Molecular Approach for the Study of Penicillin Resistance In Neisseria meningitidis. Humana Press eBooks. 67. 107–119. 8 indexed citations
6.
Arreaza, L., et al.. (2003). Sequencing of Neisseria meningitidis penA Gene: the Key to Success in Defining Penicillin G Breakpoints. Antimicrobial Agents and Chemotherapy. 48(1). 358–359. 11 indexed citations
7.
Vázquez, Julio A., L. Arreaza, Colin Block, et al.. (2003). Interlaboratory Comparison of Agar Dilution and Etest Methods for Determining the MICs of Antibiotics Used in Management of Neisseria meningitidis Infections. Antimicrobial Agents and Chemotherapy. 47(11). 3430–3434. 45 indexed citations
8.
Arreaza, L., et al.. (2003). Development of a Multilocus Sequence Typing Method for Analysis of Listeria monocytogenes Clones. Journal of Clinical Microbiology. 41(2). 757–762. 158 indexed citations
9.
Arreaza, L.. (2002). What about antibiotic resistance in Neisseria lactamica?. Journal of Antimicrobial Chemotherapy. 49(3). 545–547. 15 indexed citations
10.
Arreaza, L.. (2002). Antibiotic resistance of Neisseria gonorrhoeae in Spain: trends over the last two decades. Journal of Antimicrobial Chemotherapy. 51(1). 153–156. 15 indexed citations
11.
Arreaza, L., et al.. (2002). Capsule Switching among C:2b:P1.2,5 Meningococcal Epidemic Strains after Mass Immunization Campaign, Spain. Emerging infectious diseases. 8(12). 1512–1514. 43 indexed citations
12.
Arreaza, L., et al.. (2002). Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. Journal of Medical Microbiology. 52(1). 75–77. 15 indexed citations
13.
Alcalá, B., et al.. (2002). The epidemic wave of meningococcal disease in Spain in 1996–1997: probably a consequence of strain displacement. Journal of Medical Microbiology. 51(12). 1102–1106. 16 indexed citations
14.
Arreaza, L., et al.. (2000). Investigation for a more virulent variant among the C:2b:P1.2,5 Spanish meningococcal epidemic strains by molecular epidemiology. Journal of Medical Microbiology. 49(12). 1079–1084. 8 indexed citations
15.
Arreaza, L. & Julio A. Vázquez. (2000). [Meningococcus carriers: an enigma at the end of the 20th Century].. PubMed. 18(7). 352–5. 3 indexed citations
16.
Arreaza, L., L. de la Fuente, & Julio A. Vázquez. (2000). Antibiotic Susceptibility Patterns of Neisseria meningitidis Isolates from Patients and Asymptomatic Carriers. Antimicrobial Agents and Chemotherapy. 44(6). 1705–1707. 32 indexed citations
17.
Arreaza, L., et al.. (2000). [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].. PubMed. 13(2). 182–6. 1 indexed citations
18.
Arreaza, L., et al.. (1999). Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiology and Infection. 123(3). 349–357. 28 indexed citations
19.
Arreaza, L., et al.. (1999). High genetic identity within the C:2b:P1.2,5 meningococcal epidemic strain in Galicia (Spain). Clinical Microbiology and Infection. 5(5). 292–293. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026